Fusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit

HAMILTON, ON and BOSTON, June 16, 2023 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present in a fireside chat at the…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.